Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation

Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke, Stroke, 22, 983, 10.1161/01.STR.22.8.983 Benjamin, 1995, Left atrial size and the risk of stroke and death, Circulation, 92, 835, 10.1161/01.CIR.92.4.835 Chung, 2001, C-reactive protein elevation in patients with atrial arrhythmias, Circulation, 104, 2886, 10.1161/hc4901.101760 Dernellis, 2001, C-reactive protein and paroxysmal atrial fibrillation, Acta Cardiol, 56, 375, 10.2143/AC.56.6.2005701 Bruins, 1997, Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia, Circulation, 65, 1180 Frustaci, 1997, Histological substrate of atrial biopsies in patients with lone atrial fibrillation, Circulation, 96, 1180, 10.1161/01.CIR.96.4.1180 Harris, 1999, Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly, Am J Med, 106, 506, 10.1016/S0002-9343(99)00066-2 Ridker, 2000, Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men, Circulation, 101, 1767, 10.1161/01.CIR.101.15.1767 Ridker, 1999, Inflammation, atherosclerosis, and cardiovascular risk, Blood Coagul Fibrinolysis, 10, S9 Ridker, 1998, Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women, Circulation, 98, 731, 10.1161/01.CIR.98.8.731 Ridker, 2001, Role of inflammatory biomarkers in prediction of coronary heart disease, Lancet, 358, 946, 10.1016/S0140-6736(01)06112-8 Lip, 1996, Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation, Circulation, 94, 425, 10.1161/01.CIR.94.3.425 Lip, 1995, Does atrial fibrillation confer a hypercoagulable state?, Lancet, 346, 1313, 10.1016/S0140-6736(95)92339-X Cermak, 1993, C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor, Blood, 82, 513, 10.1182/blood.V82.2.513.513 Neumann, 1997, Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity, Arterioscler Thromb Vasc Biol, 17, 3399, 10.1161/01.ATV.17.12.3399 Burstein, 1997, Cytokines, platelet production and hemostasis, Platelets, 8, 93, 10.1080/09537109709169324 Amrani, 1990, Regulation of fibrinogen biosynthesis, Blood Coagul Fibrinolysis, 1, 443, 10.1097/00001721-199010000-00013 Burstein, 1996, Cytokine-induced alteration of platelet and hemostatic function, Stem Cells, 14, 154, 10.1002/stem.5530140720 Yudkin, 1999, C-reactive protein in healthy subjects, Arterioscler Thromb Vasc Biol, 19, 972, 10.1161/01.ATV.19.4.972 Conway DSG, Buggins P, Hughes EA, et al. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 2004;43:2075–82 Conway, 2003, Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation, Circulation, 107, 3133, 10.1161/01.CIR.0000077912.12202.FC Lip, 2002, Antithrombotic therapy for atrial fibrillation, BMJ, 325, 1022, 10.1136/bmj.325.7371.1022